Tennis elbow clinical trial at Dunedin School of Medicine
Tennis elbow clinical trial at the Dunedin School of Medicine, patients and funding wanted
(PR.co.nz)
Globally, 3% of the population suffers from a Tennis Elbow
(lateral epicondylitis) inflammation. A highly successful
experimental device has been recently tested in Germany
using a very densed acoustic pressure which loosens both
inflammation and scar tissue in only 24 hours.
An
exclusive clinical trial will be conducted at the Dunedin
School of Medicine. For this clinical trial we need both
patients who have suffered more than 12 months as well as
funding.
We believe this technology can also be
applied to other inflammation related conditions such as
golfers arm, lower back pain, ballet injuries and even
tendon injuries in horses.
Musculoskeletal
conditions account for the third leading cause of health
systems expenditure in Australia. Lateral epicondylalgia
(tennis elbow) is such a condition and is often treated in
primary care. Both the individual and community are affected
by this condition: 7 per 1000 patients seeing their medical
doctor have this condition. Most are not tennis related. On
average 10-30% of sufferers take 12 weeks off work. The
condition may last 6-48 months and it tends to become
stubborn to treatment and recurs
often.
ends